Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study

McAllister, P; Winner, PK; Ailani, J; Buse, DC; Lipton, RB; Chakhava, G; Josiassen, MK; Lindsten, A; Mehta, L; Ettrup, A; Cady, R

Cady, R (通讯作者)，Lundbeck LLC, Deerfield, IL 60015 USA.

JOURNAL OF HEADACHE AND PAIN, 2022; 23 (1):

Abstract

Background: Demonstrating therapeutic value from the patient perspective is important in patient-centered migraine management. The objective of this s......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索